Moreover, the prognosis of the high-expression group of SLC12A5 was significantly better than that of the low-expression group, indicating a significant correlation between SLC12A5 expression and prognosis in gliomas (Fig. S1d-g). The gene discussed is SLC12A5; the disease is central nervous system cancer.